An international workshop co-led by University of Miami Miller School of Medicine neurologist Michael Benatar, M.D., Ph.D., laid the foundation for developing guidance for the clinical care of people at elevated genetic risk for amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). Read the full article here.